TEVA-COTRIDIN EXPECTORANT
Google image searchProduct monograph
Active ingredients
triprolidine hydrochloride, 2 MG/5 ML
pseudoephedrine hydrochloride, 30 MG/5 ML
guaifenesin, 100 MG/5 ML
codeine phosphate, 10 MG/5 ML
DIN: 02053403
Dosage form(s): SYRUP
Route(s) of administration: ORAL
Schedule: Narcotic (CDSA I)
Company: TEVA CANADA LIMITED
Date: 05-MAR-2018
ATC:
- R05 — COUGH AND COLD PREPARATIONS (ATC, ATC/DDD, )
- R05F — COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS (ATC, ATC/DDD)
- R05FA — Opium derivatives and expectorants (ATC, ATC/DDD)
- R05FA02 — OPIUM DERIVATIVES AND EXPECTORANTS (ATC/DDD)
Pharmaceutical standard: USP
External Links for Teva-Cotridin Expectorant
Search on Google
- Teva-Cotridin Expectorant side effects
- Teva-Cotridin Expectorant dosage
- triprolidine hydrochloride side effects
- triprolidine hydrochloride dosage
- pseudoephedrine hydrochloride side effects
- pseudoephedrine hydrochloride dosage
- guaifenesin side effects
- guaifenesin dosage
- codeine phosphate side effects
- codeine phosphate dosage
Teva Canada Limited
Go to Teva website to see drug product details. Sometimes you can find teva-cotridin expectorant photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.
